Certified PEP MEX Expands Its Reach in Mexico With Two New Research Peptide Websites

Nov 7, 2026

Péptidos Verificados brings the full catalog together for online purchase, while Péptido Retatrutida focuses on a molecule as it rounds out its Phase 3 program.

Mexico City, Mexico, November 7, 2026 -- Mexico City, Mexico, 7th November – Certified PEP MEX is a research peptide company that supplies research-use-only (RUO) compounds, and today it announced it is expanding its reach in Mexico with two new websites: Péptidos Verificados at https://peptidosverificados.mx/, where every item in the catalog is available for purchase, and Péptido Retatrutida at https://peptido-retatrutida.mx/, which focuses specifically on retatrutide.

The announcement comes as interest in research peptides continues to grow in the country. Péptidos Verificados brings together 39 compounds in 48 presentations, each with a batch-specific certificate of analysis (COA) and FedEx shipping across Mexico from the official store at https://certified-peptidos.mx/. Péptido Retatrutida offers detailed information on the triple-receptor molecule just as its clinical development approaches a key regulatory stage.

“More and more researchers in Mexico are looking for peptides with documentation they can verify for themselves, and we wanted to give them one clear site with the full catalog and another dedicated to retatrutide as it rounds Phase 3,” said Benson Jamison of Certified PEP. “Every vial carries a QR code that opens the lab report for its batch.”

What Each Site Offers

  • Péptidos Verificados presents the full catalog with a product page, presentation and batch COA for every compound, a dedicated GLP collection, a Spanish-language research library and local pages for sixteen Mexican cities. Every product can be purchased directly on the site, with payment in Mexican pesos.
  • Péptido Retatrutida centers on retatrutide (LY-3437943), a triple agonist of the GLP-1, GIP and glucagon receptors. It includes batch specifications, the COA issued by Vanguard Laboratory, and guides to reading a certificate of analysis and comparing the molecule with tirzepatide and semaglutide.

Prices and availability may change without notice.

Retatrutide: Phase 3 Enters the Home Stretch

On July 23, 2026, Eli Lilly announced positive results from the Phase 3 TRIUMPH-2 and TRIUMPH-3 trials, bringing the total to five positive Phase 3 studies for retatrutide. The company plans to submit a Biologics License Application (BLA) to the FDA in the first quarter of 2027.

Retatrutide remains an investigational compound and is not approved as a medicine by the FDA or COFEPRIS. The material offered by Certified PEP MEX is a research-grade compound, distinct from the pharmaceutical product used in clinical trials, and is sold strictly for laboratory use. None of the clinical results mentioned constitute claims about Certified PEP MEX products.

Quality and Transparency

Certified PEP MEX peptides are manufactured in the United States in a cGMP-compliant facility and tested by independent laboratories, most often Vanguard Laboratory in Olympia, Washington, which is accredited under ISO/IEC 17025:2017. Every batch has its own COA, and the QR code on each vial opens the report directly on the testing laboratory’s own website.

Research Use Only: Certified PEP MEX products are intended solely for in-vitro laboratory research and are not intended for human or veterinary use, consumption, clinical use, diagnosis, treatment or prevention of disease. No dosing or administration information is provided. Statements in this release have not been evaluated by the U.S. Food and Drug Administration or by COFEPRIS in Mexico.

About Certified PEP MEX

Certified PEP MEX supplies peptides and compounds for qualified laboratory research in Mexico. The company emphasizes U.S. manufacturing, batch-specific independent testing, product labeling with COA information, transparent documentation and customer support in Mexico. Certified PEP MEX products are intended solely for in-vitro laboratory research and are not intended for human or veterinary use or clinical applications.

Contact Info:
Name: Benson Jamison
Email: Send Email
Organization: Certified PEP MEX
Phone: 52 55 8526 4324
Website: https://certified-peptidos.mx/

Release ID: 89208820

In case of identifying any problems, concerns, or inaccuracies in the content shared in this press release, or if a press release needs to be taken down, we urge you to notify us immediately by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will be readily accessible to address your concerns and take swift action within 8 hours to rectify any issues identified or assist with the removal process. We are committed to delivering high-quality content and ensuring accuracy for our valued readers.

More News

Tesla Is Ending Production of Its Cybertruck and Refocusing on the Cybercab
Nov 6, 2026
Tesla Is Ending Production of Its Cybertruck and Refocusing on the Cybercab

Production of the electric trucks will stop in the middle of 2027 to make room for increased production of its autonomous ride-share vehicle, Elon Musk said.

Why smoky bacon crisps threaten to reignite rows over EU rules
Nov 6, 2026
Why smoky bacon crisps threaten to reignite rows over EU rules

A post-Brexit deal on food standards has raised questions over the future naming of the classic British snack.

What Shaped Anthropic CEO Dario Amodei’s Thinking on A.I.
Nov 6, 2026
What Shaped Anthropic CEO Dario Amodei’s Thinking on A.I.

Some call him a doomer. Others see him as a responsible technologist. Here’s how Dario Amodei’s thinking on artificial intelligence was shaped.

Food bank to close amid rising costs
Nov 6, 2026
Food bank to close amid rising costs

A food bank in Goole annouces it will close in January as costs rise and donations drop.

Winter support for residents facing cost pressures
Nov 6, 2026
Winter support for residents facing cost pressures

The plans aim to help more people access food, financial advice and help with heating costs.

A.I. Was Supposed to Come for Our Jobs. So Far, Evidence Is Mixed.
Nov 6, 2026
A.I. Was Supposed to Come for Our Jobs. So Far, Evidence Is Mixed.

White collar industries that are most exposed to artificial intelligence continued to add jobs in October, although that growth has been weak.

PM tells firms to publish salaries in job adverts ahead of new law
Nov 6, 2026
PM tells firms to publish salaries in job adverts ahead of new law

The government argues the change will help jobseekers and could help to prevent pay discrimination.

Workers' rights 'second place' to economic growth
Nov 6, 2026
Workers' rights 'second place' to economic growth

Jersey's Economic Development Minister has told the BBC that workers' rights may have to take 'second place' to economic growth.

Stable Labor Market Keeps Fed on Track to Raise Rates Gradually
Nov 6, 2026
Stable Labor Market Keeps Fed on Track to Raise Rates Gradually

The Federal Reserve decided against raising interest rates at its meeting last week, but it is widely expected to move again in December to help tame inflation.

Global stocks plunge as fears over US AI slowdown spread to Asia and Europe
Nov 6, 2026
Global stocks plunge as fears over US AI slowdown spread to Asia and Europe

Investors have reacted to possible tougher scrutiny of data centre construction and the AI industry.

After a $2.5 Trillion Wipeout, Tech Investors Brace for More Pain
Nov 6, 2026
After a $2.5 Trillion Wipeout, Tech Investors Brace for More Pain

A stock rally fueled in part by artificial intelligence is being tested after Democrats’ landslide election victories.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter